Quality-Adjusted Time Without Symptoms Of Disease Progression Or Toxicity Analysis Of Mirvetuximab Soravtansine Versus Investigator’s Choice Of Chemotherapy In Folate Receptor-Alpha Positive, Platinum-Resistant Ovarian Cancer

ESGO eAcademy, Felix Hilpert, 4151599

Panel discussion and audience Q&A

ESGO eAcademy, Domenica Lorusso, 4151598

Introducing ADCs into Clinical Practice: What Do We Need to Anticipate?

ESGO eAcademy, Susana Banerjee, 4151597

What Could Be the Options of Post Immunotherapy?

ESGO eAcademy, Sandro Pignata, 4151593

Biomarker testing in advanced OC: what do we need to test for now?

ESGO eAcademy, Elena Ioanna Braicu, 4151596

Chemo Free Treatment in Endometrial Cancer

ESGO eAcademy, Christian Marth, 4151592

Treatment Landscape in Endometrial Cancer

ESGO eAcademy, Isabelle Ray-Coquard, 4151591

Four Live Scans and Clinical Cases

ESGO eAcademy, Antonia Carla Testa, 4151590

Parametrial Assessment and Pelvic Side Wall Assessment

ESGO eAcademy, Antonia Carla Testa, 4151589

Systematic Approach for Cervical Cancer Staging

ESGO eAcademy, Daniela Fischerova, 4151588

Introduction of Ultrasound in Cervical Cancer, including Scientific Results and Role in Current Guidelines (ESGO/ESTRO/ESP, FIGO)

ESGO eAcademy, Elisabeth Epstein, 4151587

ASGO - ESGO 3rd Joint Webinar: Multidisciplinary Guidelines for the Management of Uterine Sarcomas

ESGO eAcademy, Faculty / Presenter(s), 4151900

Patient advocacy

ESGO eAcademy, Faculty / Presenter(s), 4151918

Vaginal and Vulvar Cancer

ESGO eAcademy, Faculty / Presenter(s), 4151917

Ovarian cancer

ESGO eAcademy, Faculty / Presenter(s), 4151916

Endometrial cancer

ESGO eAcademy, Faculty / Presenter(s), 4151915

Cervical cancer

ESGO eAcademy, Faculty / Presenter(s), 4151914

DDI - Ovarian cancer

ESGO eAcademy, Faculty / Presenter(s), 4151340

DDI - Vulvar cancer

ESGO eAcademy, Faculty / Presenter(s), 4151339

DDI - Uterine cancer

ESGO eAcademy, Faculty / Presenter(s), 4151338

DDI - Cervical cancer

ESGO eAcademy, Faculty / Presenter(s), 4151337

Meet the Surgeon: From lymhadenectomy to SN in vulvar cancer by Ate Van der Zee

ESGO eAcademy, Faculty / Presenters, 4147949

Seeking Equality in Surgery: Do we blame the Tools?

ESGO eAcademy, Faculty / Presenters, 4147825

Tumour board 16: Current development and controversies in Endometrial Cancer

ESGO eAcademy, Faculty / Presenter(s), 4151183

Vulvar and vaginal cancer epidemiology and screening

ESGO eAcademy, Faculty / Presenter(s), 4150732

Debates in EC Management: How to choose First-Line therapy for your metastatic EC patient

ESGO eAcademy, Faculty / Presenter(s), 4150267

4th webinar: Leadership training: What women need to know

ESGO eAcademy, Faculty / Presenter(s), 4150693

The Challenge of sparing the uterus in pelvic oncology by Reitan Ribeiro

ESGO eAcademy, Faculty / Presenter(s), 4150261

ASGO - ESGO 2nd Joint Webinar on The Role of Surgery in Recurrent Ovarian Cancer in the Era of Targeted Therapy

ESGO eAcademy, Faculty / Presenter(s), 4150064

Simplifying Type C1 Radical Hysterectomy by following the Hypogastric Nerve Plate-Line

ESGO eAcademy, Ilker Selcuk, 4148054

Selective Systematic Nerve-Sparing Type C2 Radical Hysterectomy (Type C2N, Selcuk Technique for Nerve-Sparing Radical Hysterectomy)

ESGO eAcademy, Ilker Selcuk, 4148053

ENYGO&YEARS: Robotic radical hysterectomy - my way

ESGO eAcademy, Faculty / Presenter(s), 4150695

Paraaortic Lymphadenectomy

ESGO eAcademy, Faculty / Presenter(s), 4147953

Colpectomy

ESGO eAcademy, Jorge Ariel Perez, 4147658

3rd webinar: How can I integrate my family life with my career? How can/should employers and colleagues support this balance?

ESGO eAcademy, Faculty / Presenter(s), 4147213

Endometrial cancer prevention

ESGO eAcademy, Faculty / Presenter(s), 4145883

Palliative surgery by Giovanni Aletti

ESGO eAcademy, Faculty / Presenter(s), 4145758

Tumor board 15: Locally advanced cervical cancer

ESGO eAcademy, Faculty / Presenter(s), 4142466

New FIGO classification of endometrial cancers

ESGO eAcademy, Faculty / Presenter(s), 4142501

Multidisciplinary Tumour Board Dialogues – Endometrial cancer – Clinical cases discussions - June 29th, 2024

ESGO eAcademy, Faculty / Presenter(s), 4140553

Multidisciplinary Tumour Board Dialogues – Endometrial cancer – Clinical cases discussions - June 28th, 2024

ESGO eAcademy, Faculty / Presenter(s), 4140552

ASGO - ESGO 1st Joint Webinar on Fertility Preservation in gyneacologic cancers

ESGO eAcademy, Faculty / Presenter(s), 4140549

2nd webinar: But what is harassment?

ESGO eAcademy, Faculty / Presenter(s), 4139872

Technique of Radical Hysterectomy

ESGO eAcademy, Faculty / Presenter(s), 4139871

SESSION 1- Understanding the magnitude of the disease

ESGO eAcademy, Faculty / Presenter(s), 4136521

SESSION 2: Prevention of cervical cancer in Africa

ESGO eAcademy, Faculty / Presenter(s), 4136522

SESSION 3: Colposcopy and diagnosis

ESGO eAcademy, Faculty / Presenter(s), 4136523

SESSION 4: Risk-stratified treatment for pre-invasive and invasive carcinoma for LMIC

ESGO eAcademy, Faculty / Presenter(s), 4136524

HPV prevention in pregnancy

ESGO eAcademy, Faculty / Presenter(s), 428502

1st Webinar: We are all gender biased. So what?

ESGO eAcademy, Faculty / Presenter(s), 424836

A practical movie of an ERAS program by Pedro Ramirez

ESGO eAcademy, Faculty / Presenter(s), 422448

Lymph node assessment in vulvar cancer – VITA consensus

ESGO eAcademy, Faculty / Presenter(s), 418988

Tumour board 14: Cervial Cancer in Pregnancy

ESGO eAcademy, Faculty / Presenter(s), 417394

Exposure and paraaortic lymphadenectomy in patients with BMI > 40.

ESGO eAcademy, Hubert Fornalik, 412380

Invitation to ESGO 2025 in Rome

ESGO eAcademy, Anna Fagotti, 411169

Young Investigator Award

ESGO eAcademy, Nicole Concin, 411168

Best Runners Awards

ESGO eAcademy, Nicole Concin, 411167

Summary of the Congress

ESGO eAcademy, Nicole Concin, 411166

SUCCOR 10 Years: Vision A Decade After Radical Surgery As Primary Treatment For Cervical Cancer.

ESGO eAcademy, Nabil Manzour Sifontes, 411161

Total Mesometrial Resection: Open Surgical Technique

ESGO eAcademy, Selçuk Erk?l?nç, 411155

Management of Late Urinary Complications

ESGO eAcademy, Giuseppe Vizzielli, 411165

Tumor Treating Fields (TTFields) therapy in platinum-resistant ovarian cancer: Results from the ENGOT-ov50 / GOG-3029 / INNOVATE-3 phase 3 study

ESGO eAcademy, Ignace Vergote, 411159

Boari Flap Technique In Urinari Reconstruction In Gynecological Cancer

ESGO eAcademy, Marta de la Cruz, 411153

Principle of Bladder Reconstruction and Urinary Diversion

ESGO eAcademy, Gwenael Ferron, 411164

Laparoscopic Extraperitoneal Debulking Of Enlarged Para-Aortic Lymph Node In Patient With Endometrial Carcinoma Recurrence.

ESGO eAcademy, Andrea Ungredda, 411152

Discussant - LEAP 001 trail

ESGO eAcademy, Domenica Lorusso, 411157

How to Manage Intraoperatively a Ureteral Injury?

ESGO eAcademy, Giovanni Aletti, 411163

Lenvatinib Plus Pembrolizumab Versus Chemotherapy As First-Line Therapy For Advanced Or Recurrent Endometrial Cancer: Primary Results Of The Phase 3 ENGOT-en9/LEAP-001 Study

ESGO eAcademy, Christian Marth, 411156

V-NOTES Sentinel Lymph Node Mapping For Endometrial Carcinoma

ESGO eAcademy, Selçuk Erk?l?nç, 411151

ESGO Gynae-Cancers Algorithms App Presentation

ESGO eAcademy, Enora Laas, 411144

The Role of Minimally Invasive Surgery in Cervical Cancer

ESGO eAcademy, Charalampos Theofanakis, 411147

Mucinous Ovarian Cancer, What We Have to Know Now and in the Future

ESGO eAcademy, Jonathan Ledermann, 411143

Molecular Classification of Endometrial Cancer: Significance and Limitations from a Surgeon’s Perspective

ESGO eAcademy, Mario Leitao Jr., 411150

Granulosa Cell Tumours, What We Have to Know Now and in the Future

ESGO eAcademy, Michael Friedlander, 411142

The Role of Neoadjuvant Chemotherapy in the Management of Cervical Cancer

ESGO eAcademy, Michael Halaska, 411146

Staging of Endometrial Cancer in the Molecular Era

ESGO eAcademy, Frederic Amant, 411149

The Case of Small Cell Ovarian Tumours, What We Have to Know Now and in the Future

ESGO eAcademy, Isabelle Ray-Coquard, 411141

De-Escalation of Surgery for Cervical Cancer and Fertility-Sparing Management

ESGO eAcademy, Ane Gerda Z Eriksson, 411145

Training and Quality Assurance

ESGO eAcademy, Elisabeth Epstein, 411134

Systemic and Radiotherapeutic Management in Locally Advanced Vulvar Cancer – Who Should We Rather Not Operate

ESGO eAcademy, Sven Mahner, 411140

New Challenging Indications for Oncological Robotic Surgery

ESGO eAcademy, Jordi Ponce, 411137

Diagnostic and Surgical Management of the Vulva in Locally Advanced Vulvar Cancer – Who Should We Operate

ESGO eAcademy, Ignacio Zapardiel, 411139

MIS by Robotics on Interval Surgery for Ovarian Cancer

ESGO eAcademy, Anna Fagotti, 411136

Image-Guided Biopsy (Imaging Guidance, Sampling Methods)

ESGO eAcademy, Elisabeth Epstein, 411131

The Role of Robotics as a New Cervical Cancer Approach

ESGO eAcademy, Henrik Falconer, 411135

Project Introduction, General Recommendations

ESGO eAcademy, Daniela Fischerova, 411130

Whole Exome Sequencing In Vulvar Squamous Cell Carcinomas Identifies Impaired Prognosis Of Patients With TP53 Mutations Combined With CCND1 Gains

ESGO eAcademy, Nuria Carreras Dieguez, 411120

Quality of life for health care providers

ESGO eAcademy, Vesna Kesic, 411124

Endometriosis And Ovarian Cancer: Related Or Associated? Exploring Differences And Similarities

ESGO eAcademy, Giulia Dondi, 411118

Radiation and Surgical QI in Cervical Cancer

ESGO eAcademy, Christina Fotopoulou, 411127

The Role of Meaning and Dignity in the End-of-Life Care

ESGO eAcademy, Elisabeth Andritsch, 411123

Update On The Role Of Intraoperative Indocyanine Green Fluorescence Angiography In Preventing Anastomotic Leakage After Colorectal Resection In Cytoreductive Surgery For Advanced Ovarian Cancer

ESGO eAcademy, Livia Xhindoli, 411116

What Do You Need to Know about Sexuality Issues in Cancer Patients

ESGO eAcademy, Vesna Kesic, 411122

Should We Abandon Retroperitoneal Staging in Locally Advanced Cervical Cancer? CON

ESGO eAcademy, Berta Diaz-Feijoo, 411126

Should We Abandon Retroperitoneal Staging in Locally Advanced Cervical Cancer? PRO

ESGO eAcademy, Nadeem R. Abu-Rustum, 411125

Counselling for Fertility Preservation

ESGO eAcademy, Joachim Weis, 411121

Systemic Therapies in Relapse Setting for ‘Aggressive Histologies‘

ESGO eAcademy, Isabelle Ray-Coquard, 411111

Niraparib Maintenance Therapy Using An Individualised Starting Dose In Patients With Platinum-Sensitive Recurrent Ovarian Cancer (NORA): Final Overall Survival Analysis Of A Randomised, Double-Blind, Placebo-Controlled Phase 3 Trial

ESGO eAcademy, Xiaohua Wu, 411104

ViRP Signature Predicts Response To Treatment With Chemotherapy And Bevacizumab In Ovarian Cancer - A Translational Study Of The ICON-7 Trial”

ESGO eAcademy, Kristina Lindemann, 411103

Which Efficient Therapies for Low-Ggrade ESS or AS and Miscellenous Rare Entities

ESGO eAcademy, Michael Friedlander, 411110